Todd C. Brady

Insider Reports History

Entity
Individual
Location
C/O Evoke Pharma, Inc., 505 Lomas Santa Fe Drive, Solana Beach, CA
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Todd C. Brady
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd C. Brady:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aldeyra Therapeutics, Inc. President and CEO, Director Common Stock 1.47M $4.49M $3.05 Mar 12, 2024 Direct
Aldeyra Therapeutics, Inc. President and CEO, Director Stock Option (right to buy) 1.08M Mar 9, 2024 Direct
Evoke Pharma Inc Director Stock Option (Right to Buy) 14.6K May 22, 2024 Direct
F-star Therapeutics, Inc. Director Common Stock 0 $7.12 Mar 8, 2023 Direct
F-star Therapeutics, Inc. Director Warrant (right to buy) 0 Nov 20, 2020 Direct

Insider Reports Filed by Todd C. Brady

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EVOK Evoke Pharma Inc May 22, 2024 1 $0 4 May 24, 2024 Director
ALDX Aldeyra Therapeutics, Inc. Mar 9, 2024 3 -$581K 4 Mar 12, 2024 President and CEO, Director
ALDX Aldeyra Therapeutics, Inc. Sep 7, 2023 7 -$382K 4 Sep 11, 2023 President and CEO, Director
EVOK Evoke Pharma Inc May 10, 2023 1 $0 4 May 11, 2023 Director
ALDX Aldeyra Therapeutics, Inc. Feb 28, 2023 2 $0 4 Mar 2, 2023 President and CEO, Director
ALDX Aldeyra Therapeutics, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 President and CEO, Director
ALDX Aldeyra Therapeutics, Inc. Jun 23, 2022 1 $59.5K 4 Jun 27, 2022 President and CEO, Director
FSTX F-star Therapeutics, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
EVOK Evoke Pharma Inc Apr 27, 2022 1 $0 4 Apr 28, 2022 Director
ALDX Aldeyra Therapeutics, Inc. Mar 30, 2022 3 $0 4 Apr 1, 2022 President and CEO, Director
FSTX F-star Therapeutics, Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director
EVOK Evoke Pharma Inc May 5, 2021 1 $0 4 Jul 23, 2021 Director
FSTX F-star Therapeutics, Inc. Nov 20, 2020 9 -$107K 4 Mar 9, 2023 Director